Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 22.41B 3.31B 2.89B 2.67B 2.47B 4.65B 318B 4.74B 31.88B 12.51B 156B 12.43B 12.16B 536B P/E 2026 *
15.1x
P/E 2027 * 13.1x
Enterprise Value 18.89B 2.79B 2.44B 2.25B 2.08B 3.92B 268B 3.99B 26.87B 10.54B 131B 10.48B 10.25B 452B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 0.56x
Free-Float
34.77%
Yield 2026 *
4.58%
Yield 2027 * 5.05%
1 day+8.85%
1 week+12.59%
Current month+30.94%
1 month+14.55%
3 months+15.36%
6 months+5.02%
Current year+11.69%
1 week 17.36
Extreme 17.36
19.8
1 month 14.39
Extreme 14.39
19.8
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+8.85%+12.59%+13.36%-27.51% 3.31B
+1.52%+0.54%-17.27%-27.64% 15.05B
+1.82%-3.45%-26.48%-32.80% 6.81B
+0.71%-2.31%-20.72%-6.79% 5.95B
+3.14%+5.85%-12.10%-30.29% 3.82B
-0.49%-2.10%-29.10%-48.47% 3.16B
-0.59%-7.44%-38.67%-15.23% 3.12B
-1.54%-0.75%+94.56% - 2.51B
0.00%-3.75%-20.63%-3.23% 2.48B
-0.34%0.00%+1.15%+35.19% 1.7B
Average +1.31%+0.71%-5.59%-17.42% 4.79B
Weighted average by Cap. +1.52%+1.09%-12.31%-22.80%

Financials

2026 *2027 *
Net sales 29.91B 4.42B 3.86B 3.57B 3.3B 6.21B 424B 6.32B 42.54B 16.69B 208B 16.59B 16.22B 715B 33.03B 4.88B 4.26B 3.94B 3.64B 6.86B 468B 6.98B 46.99B 18.44B 229B 18.32B 17.91B 790B
Net income 1.48B 219M 192M 177M 164M 308M 21.05B 314M 2.11B 829M 10.31B 823M 805M 35.5B 1.71B 253M 221M 205M 189M 356M 24.31B 362M 2.44B 957M 11.91B 951M 930M 41B
Net Debt -3.52B -520M -454M -420M -388M -730M -49.91B -744M -5.01B -1.96B -24.44B -1.95B -1.91B -84.15B -4.01B -592M -517M -478M -442M -832M -56.87B -847M -5.7B -2.24B -27.85B -2.22B -2.17B -95.88B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
14/07/26 CNY 19.68 +8.85% 19,782,719
13/07/26 CNY 18.08 +2.44% 8,920,661
10/07/26 CNY 17.65 0.00% 7,824,491
09/07/26 CNY 17.65 -0.90% 7,836,718
08/07/26 CNY 17.81 +1.89% 10,028,106
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
19.68CNY
Average target price
24.70CNY
Spread / Average Target
+25.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock